Medications & Supplements/Prescription Drugs

American Health Packaging Verapamil Tablets Recalled for Dissolution Issues

Agency Publication Date: March 6, 2023

Summary

Amerisource Health Services LLC is recalling 422 cartons of American Health Packaging Verapamil Hydrochloride (verapamil) Extended-Release Tablets, USP, 120 mg. The medication failed dissolution testing, meaning the tablets may release the active ingredient faster than specified. This prescription drug is used to treat high blood pressure and certain heart conditions. No injuries or adverse events have been reported to date regarding this issue.

Risk

The tablets dissolved at a rate above specified values, which could lead to the medication being released into the body too quickly. This may cause inconsistent blood pressure control or other cardiovascular side effects.

What You Should Do

This recall affects American Health Packaging Verapamil Hydrochloride Extended-Release Tablets, USP, 120 mg, sold in 100-tablet cartons (NDC 60687-493-01) consisting of 10 unit-dose strips of 10 tablets (NDC 60687-493-11).
Check your medication packaging for lot number 1009065 with an expiration date of 12/31/2023.
If you have health concerns, contact your healthcare provider or pharmacist. Return any unused product to the place of purchase for a refund, throw it away, or contact Amerisource Health Services LLC for further instructions.
Call the FDA Consumer Complaint hotline at 1-888-723-3332 (1-888-SAFEFDA) for additional questions.

Your Remedy Options

You have 2 options:

Option 1: Full Refund

How to: Contact your healthcare provider or pharmacist for guidance, or return any unused product to the place of purchase for a refund

Option 2: Dispose of Product

How to: Throw the product away. For prescription medications, a DEA take-back location or pharmacy mail-back program is preferred when available.

Affected Products

Product: Verapamil Hydrochloride Extended-Release Tablets, USP (120 mg)by American Health Packaging

Variants: 120 mg, Extended-Release, Tablet

Lot Numbers:

1009065 (Exp 12/31/2023)

NDC:

60687-493-01

60687-493-11

100 Tablets per Carton (10 x 10 unit doses). Distributed by American Health Packaging.

Additional Information

Agency: Food and Drug Administration (FDA)

Event ID: 91670

Status: Resolved

Manufacturer: Amerisource Health Services LLC

Sold By: American Health Packaging

Manufactured In: United States

Units Affected: 422 cartons

Distributed To: Nationwide

Were You Affected by This Recall?

If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.

Find an Attorney

This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.

AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.

Sources: FDA iRES · Raw API Response

openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.

Summary

What You Should Do

This recall affects American Health Packaging Verapamil Hydrochloride Extended-Release Tablets, USP, 120 mg, sold in 100-tablet cartons (NDC 60687-493-01) consisting of 10 unit-dose strips of 10 tablets (NDC 60687-493-11).

Check your medication packaging for lot number 1009065 with an expiration date of 12/31/2023.

If you have health concerns, contact your healthcare provider or pharmacist. Return any unused product to the place of purchase for a refund, throw it away, or contact Amerisource Health Services LLC for further instructions.

Call the FDA Consumer Complaint hotline at 1-888-723-3332 (1-888-SAFEFDA) for additional questions.